WallStSmart

TC Energy Corp (TRP)vsWest Pharmaceutical Services Inc (WST)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

TC Energy Corp generates 396% more annual revenue ($15.24B vs $3.07B). TRP leads profitability with a 23.1% profit margin vs 16.1%. WST appears more attractively valued with a PEG of 2.89. TRP earns a higher WallStSmart Score of 59/100 (C).

TRP

Buy

59

out of 100

Grade: C

Growth: 6.0Profit: 7.5Value: 4.7Quality: 3.0
Piotroski: 4/9Altman Z: 0.48

WST

Buy

55

out of 100

Grade: C-

Growth: 4.7Profit: 8.0Value: 4.7Quality: 7.3
Piotroski: 5/9Altman Z: 4.91
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

TRPSignificantly Overvalued (-216.8%)

Margin of Safety

-216.8%

Fair Value

$19.23

Current Price

$64.08

$44.85 premium

UndervaluedFair: $19.23Overvalued
WSTSignificantly Overvalued (-256.8%)

Margin of Safety

-256.8%

Fair Value

$68.99

Current Price

$247.02

$178.03 premium

UndervaluedFair: $68.99Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

TRP4 strengths · Avg: 9.0/10
Operating MarginProfitability
45.4%10/10

Strong operational efficiency at 45.4%

Market CapQuality
$66.54B9/10

Large-cap with strong market position

Profit MarginProfitability
23.1%9/10

Keeps 23 of every $100 in revenue as profit

Revenue GrowthGrowth
16.5%8/10

16.5% revenue growth

WST2 strengths · Avg: 9.0/10
Altman Z-ScoreHealth
4.9110/10

Safe zone — low bankruptcy risk

Operating MarginProfitability
21.6%8/10

Strong operational efficiency at 21.6%

Areas to Watch

TRP4 concerns · Avg: 3.0/10
P/E RatioValuation
25.3x4/10

Moderate valuation

EPS GrowthGrowth
0.5%4/10

0.5% earnings growth

PEG RatioValuation
4.612/10

Expensive relative to growth rate

Altman Z-ScoreHealth
0.482/10

Distress zone — elevated risk

WST3 concerns · Avg: 3.3/10
P/E RatioValuation
36.1x4/10

Premium valuation, high expectations priced in

EPS GrowthGrowth
2.1%4/10

2.1% earnings growth

PEG RatioValuation
2.892/10

Expensive relative to growth rate

Comparative Analysis Report

WallStSmart Research

Bull Case : TRP

The strongest argument for TRP centers on Operating Margin, Market Cap, Profit Margin. Profitability is solid with margins at 23.1% and operating margin at 45.4%. Revenue growth of 16.5% demonstrates continued momentum.

Bull Case : WST

The strongest argument for WST centers on Altman Z-Score, Operating Margin. Profitability is solid with margins at 16.1% and operating margin at 21.6%.

Bear Case : TRP

The primary concerns for TRP are P/E Ratio, EPS Growth, PEG Ratio. Debt-to-equity of 2.23 is elevated, increasing financial risk.

Bear Case : WST

The primary concerns for WST are P/E Ratio, EPS Growth, PEG Ratio.

Key Dynamics to Monitor

TRP profiles as a growth stock while WST is a mature play — different risk/reward profiles.

WST carries more volatility with a beta of 1.18 — expect wider price swings.

TRP is growing revenue faster at 16.5% — sustainability is the question.

TRP generates stronger free cash flow (548M), providing more financial flexibility.

Bottom Line

TRP scores higher overall (59/100 vs 55/100), backed by strong 23.1% margins and 16.5% revenue growth. Both earn "Buy" and "Buy" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

TC Energy Corp

ENERGY · OIL & GAS MIDSTREAM · USA

TC Energy Corporation is an energy infrastructure company in North America. The company is headquartered in Calgary, Canada.

West Pharmaceutical Services Inc

HEALTHCARE · MEDICAL INSTRUMENTS & SUPPLIES · USA

West Pharmaceutical Services, Inc. is a designer and manufacturer of injectable pharmaceutical packaging and delivery systems. The company is headquartered in Exton, Pennsylvania.

Want to dig deeper into these stocks?